Literature DB >> 35788686

A strain-programmed patch for the healing of diabetic wounds.

Georgios Theocharidis1, Hyunwoo Yuk2,3, Heejung Roh4, Liu Wang4,5, Ikram Mezghani1, Jingjing Wu4,6, Antonios Kafanas7, Mauricio Contreras8, Brandon Sumpio1, Zhuqing Li1, Enya Wang1, Lihong Chen1, Chuan Fei Guo6, Navin Jayaswal1, Xanthi-Leda Katopodi9, Nikolaos Kalavros9, Christoph S Nabzdyk10, Ioannis S Vlachos9,11, Aristidis Veves12, Xuanhe Zhao13,14.   

Abstract

Diabetic foot ulcers and other chronic wounds with impaired healing can be treated with bioengineered skin or with growth factors. However, most patients do not benefit from these treatments. Here we report the development and preclinical therapeutic performance of a strain-programmed patch that rapidly and robustly adheres to diabetic wounds, and promotes wound closure and re-epithelialization. The patch consists of a dried adhesive layer of crosslinked polymer networks bound to a pre-stretched hydrophilic elastomer backing, and implements a hydration-based shape-memory mechanism to mechanically contract diabetic wounds in a programmable manner on the basis of analytical and finite-element modelling. In mouse and human skin, and in mini-pigs and humanized mice, the patch enhanced the healing of diabetic wounds by promoting faster re-epithelialization and angiogenesis, and the enrichment of fibroblast populations with a pro-regenerative phenotype. Strain-programmed patches might also be effective for the treatment of other forms of acute and chronic wounds.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35788686     DOI: 10.1038/s41551-022-00905-2

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  67 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  The basic science of wound healing.

Authors:  George Broughton; Jeffrey E Janis; Christopher E Attinger
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

3.  Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population.

Authors:  Linda S Geiss; Yanfeng Li; Israel Hora; Ann Albright; Deborah Rolka; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-11-08       Impact factor: 19.112

4.  Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.

Authors:  T J Wieman; J M Smiell; Y Su
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

Review 5.  The global burden of diabetic foot disease.

Authors:  Andrew J M Boulton; Loretta Vileikyte; Gunnel Ragnarson-Tennvall; Jan Apelqvist
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

6.  Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Authors:  A Veves; V Falanga; D G Armstrong; M L Sabolinski
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

Review 7.  Treating diabetic ulcers.

Authors:  Francesco Tecilazich; Thanh Dinh; Aristidis Veves
Journal:  Expert Opin Pharmacother       Date:  2011-01-18       Impact factor: 3.889

Review 8.  Emerging drugs for the treatment of diabetic ulcers.

Authors:  Francesco Tecilazich; Thanh L Dinh; Aristidis Veves
Journal:  Expert Opin Emerg Drugs       Date:  2013-05-21       Impact factor: 4.191

Review 9.  Wound repair and regeneration.

Authors:  Geoffrey C Gurtner; Sabine Werner; Yann Barrandon; Michael T Longaker
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

10.  The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.

Authors:  William A Marston; Jason Hanft; Paul Norwood; Richard Pollak
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.